疏肝和胃護(hù)膜法治療肝胃不和型膽汁反流性胃炎的理論及臨床研究
發(fā)布時(shí)間：2019-06-28 11:17
【摘要】：目的:通過(guò)觀察導(dǎo)師單兆偉教授在疏肝和胃護(hù)膜法基礎(chǔ)上創(chuàng)制的柴芍護(hù)膜湯加減治療肝胃不和型膽汁反流性胃炎(bile reflux gastritis,BRG)的臨床療效,為臨床治療BRG提供新的思路與方法。方法:①理論研究:分為現(xiàn)代醫(yī)學(xué)對(duì)BRG病因及發(fā)病機(jī)制、診斷、治療等的研究和祖國(guó)醫(yī)學(xué)對(duì)BRG的病名、病因病機(jī)、辨證分型與治療原則、治療等的研究;②臨床研究:制定肝胃不和型BRG的納入標(biāo)準(zhǔn),將符合條件的60例患者隨機(jī)分為試驗(yàn)組和對(duì)照組,試驗(yàn)組(30例)給予柴芍護(hù)膜湯加減,對(duì)照組(30例)給予枸櫞酸莫沙必利分散片和鋁碳酸鎂片,兩組均口服治療8周,利用SPSS16.0對(duì)患者臨床資料、癥狀評(píng)分,胃鏡下膽汁反流程度進(jìn)行統(tǒng)計(jì)分析。結(jié)果:治療前,兩組進(jìn)行性別、年齡、癥狀分布、膽汁反流程度分級(jí)比較,均無(wú)統(tǒng)計(jì)學(xué)差異(P均0.05),表明兩組具有可比性,且兩組均沒(méi)有出現(xiàn)不良反應(yīng)。兩組患者治療后癥狀均有不同程度的改善;對(duì)主要癥狀(脘脅脹痛或脹滿、噯氣吞酸、呃逆、惡心嘔吐、胃中嘈雜)的改善,兩組療效相當(dāng);對(duì)次要癥狀(不欲食、便溏、情緒抑郁或煩躁易怒、口干口苦)的改善方面療效存在差異(P0.05),試驗(yàn)組優(yōu)于對(duì)照組。試驗(yàn)組和對(duì)照組總有效率分別為86.7%和63.3%。兩組療效相比,試驗(yàn)組中醫(yī)證候療效優(yōu)于對(duì)照組。結(jié)論:導(dǎo)師經(jīng)驗(yàn)方柴芍護(hù)膜湯對(duì)治療肝胃不和型BRG具有良好的臨床療效,對(duì)患者整體癥狀的改善有著明顯優(yōu)勢(shì),能更好地提高病人的整體生活質(zhì)量,具有較好的臨床應(yīng)用前景。
[Abstract]:Objective: to observe the clinical effect of Chaishao protective membrane decoction, which was created by professor Shan Zhaowei, on the basis of soothing liver and stomach protective membrane, in the treatment of hepatogastric bile reflux gastritis (bile reflux gastritis,BRG), and to provide a new idea and method for clinical treatment of BRG. Methods: 1 theoretical research: it is divided into the study of etiology and pathogenesis, diagnosis and treatment of BRG in modern medicine and the study of disease name, etiology and pathogenesis, syndrome differentiation, treatment principle and treatment of BRG in traditional Chinese medicine. 2 Clinical study: 60 patients with hepatogastric disharmony type BRG were randomly divided into experimental group (n = 30) and control group (n = 30). The experimental group (n = 30) was treated with mosapride citrate dispersible tablet and magnesium aluminum carbonate tablet for 8 weeks. The clinical data, symptom score and bile reflux degree under gastroscopy were statistically analyzed by SPSS16.0. Results: before treatment, there was no significant difference in sex, age, symptom distribution and bile reflux degree between the two groups (P 0.05), indicating that the two groups were comparable, and there were no adverse reactions between the two groups. After treatment, the symptoms of the two groups were improved to varying degrees, and the improvement of the main symptoms (epigastric distension, pain or fullness, belching and acid ingestion, hiccup, nausea and vomiting, stomach noise) was the same between the two groups; there were differences in the improvement of secondary symptoms (lack of food, loose stools, depression or irritability, bitter mouth and mouth) between the two groups (P 0.05), and the experimental group was superior to the control group in improving the secondary symptoms (lack of food, loose stools, depression or irritability, bitter mouth, dry mouth and mouth). The total effective rates of the experimental group and the control group were 86.7% and 63.3%, respectively. Compared with the two groups, the curative effect of TCM syndrome in the experimental group was better than that in the control group. Conclusion: Fangchai Shaohumembrane decoction has a good clinical effect on the treatment of liver-stomach disharmony BRG, has obvious advantages in improving the overall symptoms of the patients, can improve the overall quality of life of the patients, and has a good clinical application prospect.
【學(xué)位授予單位】：南京中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R259
本文編號(hào)：2507258
[Abstract]:Objective: to observe the clinical effect of Chaishao protective membrane decoction, which was created by professor Shan Zhaowei, on the basis of soothing liver and stomach protective membrane, in the treatment of hepatogastric bile reflux gastritis (bile reflux gastritis,BRG), and to provide a new idea and method for clinical treatment of BRG. Methods: 1 theoretical research: it is divided into the study of etiology and pathogenesis, diagnosis and treatment of BRG in modern medicine and the study of disease name, etiology and pathogenesis, syndrome differentiation, treatment principle and treatment of BRG in traditional Chinese medicine. 2 Clinical study: 60 patients with hepatogastric disharmony type BRG were randomly divided into experimental group (n = 30) and control group (n = 30). The experimental group (n = 30) was treated with mosapride citrate dispersible tablet and magnesium aluminum carbonate tablet for 8 weeks. The clinical data, symptom score and bile reflux degree under gastroscopy were statistically analyzed by SPSS16.0. Results: before treatment, there was no significant difference in sex, age, symptom distribution and bile reflux degree between the two groups (P 0.05), indicating that the two groups were comparable, and there were no adverse reactions between the two groups. After treatment, the symptoms of the two groups were improved to varying degrees, and the improvement of the main symptoms (epigastric distension, pain or fullness, belching and acid ingestion, hiccup, nausea and vomiting, stomach noise) was the same between the two groups; there were differences in the improvement of secondary symptoms (lack of food, loose stools, depression or irritability, bitter mouth and mouth) between the two groups (P 0.05), and the experimental group was superior to the control group in improving the secondary symptoms (lack of food, loose stools, depression or irritability, bitter mouth, dry mouth and mouth). The total effective rates of the experimental group and the control group were 86.7% and 63.3%, respectively. Compared with the two groups, the curative effect of TCM syndrome in the experimental group was better than that in the control group. Conclusion: Fangchai Shaohumembrane decoction has a good clinical effect on the treatment of liver-stomach disharmony BRG, has obvious advantages in improving the overall symptoms of the patients, can improve the overall quality of life of the patients, and has a good clinical application prospect.
【學(xué)位授予單位】：南京中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R259
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王月忠;;中西醫(yī)結(jié)合治療膽汁反流性胃炎療效的觀察[J];中國(guó)農(nóng)村衛(wèi)生;2017年02期
2 段文強(qiáng);;左金丸合半夏瀉心湯加減治療膽汁反流性胃炎48例臨床觀察[J];中國(guó)現(xiàn)代藥物應(yīng)用;2017年02期
3 陳衛(wèi)建;;姚乃禮治療膽汁反流性胃炎經(jīng)驗(yàn)述要[J];浙江中醫(yī)雜志;2017年01期
4 莊瑞斐;顧慶華;;膽胃寧顆粒劑治療膽胃不和型膽汁反流性胃炎臨床療效觀察[J];時(shí)珍國(guó)醫(yī)國(guó)藥;2016年12期
5 郭瑞萍;;旋復(fù)代赭湯合四逆散加味治療膽汁反流性胃炎臨床觀察[J];新中醫(yī);2016年10期
6 李晟瑋;張星;戴金梁;;戴金梁教授治療膽汁反流性胃炎經(jīng)驗(yàn)總結(jié)[J];中醫(yī)藥導(dǎo)報(bào);2016年13期
7 李榕萍;曹雯;;養(yǎng)心疏肝和胃法治療原發(fā)性膽汁反流性胃炎伴焦慮抑郁的療效觀察[J];中外醫(yī)療;2016年20期
8 沙立蒙;王秀娟;;王秀娟治療膽汁反流性胃炎經(jīng)驗(yàn)[J];湖南中醫(yī)雜志;2016年06期
9 常利紅;;鋁碳酸鎂用于胃潰瘍伴膽汁反流的臨床效果觀察[J];北方藥學(xué);2016年06期
10 田雪嬌;王彥剛;;李佃貴教授濁毒學(xué)說(shuō)論治膽汁反流性胃炎經(jīng)驗(yàn)介紹[J];新中醫(yī);2016年05期
，本文編號(hào)：2507258
本文鏈接：http://sikaile.net/zhongyixuelunwen/2507258.html
最近更新
教材專著
